Type 2 Diabetes Clinical Trial
Verified date | April 2007 |
Source | Odense University Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | Denmark: National Board of Health |
Study type | Interventional |
Physical activity as treatment for patients with type 2 diabetes (T2D). Treatment of T2D is
often done by medication, changing the diet and increased physical activity. It is well
established that physical training has a positive effect on the pathology of T2D such as
increased insulin sensitivity and reduced fasting plasma glucose (7) and blood lipids (15).
It is also well known that in healthy subjects endurance training increases mitochondrial
density, lipid oxidation during submaximal exercise, and results in a number of qualitative
changes in the control of OXPHOS (24). However, the effect of physical training on the
mitochondrial function in skeletal muscle of patients with T2D has not been investigated.
The purpose of this project is to investigate the effect of physical training on the
mitochondrial respiratory function in muscles of patients with T2D. Skeletal muscle biopsies
will be taken before and after 10 weeks of physical training in patients with T2D and
matched control subjects. Mitochondria will be isolated from the muscle biopsies, and
respiratory function, free radical production and UCP3 will be determined. Furthermore,
measures of maximal oxygen consumption (VO2max), heart rate and capillary lactate
concentrations and carbohydrate and lipid oxidation will be determined partly to verify an
increased aerobic capacity and partly to investigate the changes in these factors in T2D
patients.
Status | Active, not recruiting |
Enrollment | 30 |
Est. completion date | June 2007 |
Est. primary completion date | |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Male |
Age group | 40 Years to 65 Years |
Eligibility |
Inclusion Criteria: - Male, - BMI above 26, - Age between 40 and 65, - Living a sedentary lifestyle Exclusion Criteria: - Women - BMI under 26 - Age under 40 and over 65 - Trained subjects Control subjects: relatives to type 2 diabetic patients, T2D trial subjects |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
Denmark | University of Southern Denmark and Odense University Hospital | Odense |
Lead Sponsor | Collaborator |
---|---|
Odense University Hospital |
Denmark,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Mitochondrial respiratory measurements. The investigations are carried out by two rounds - one before Christmas and one after. | |||
Secondary | VO2max | |||
Secondary | Lipid oxidation | |||
Secondary | muscle fiber type composition | |||
Secondary | muscle oxidative enzymes | |||
Secondary | mitochondrial-specific proteins (UCP3) | |||
Secondary | mitochondrial production of free oxygen radicals |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05219994 -
Targeting the Carotid Bodies to Reduce Disease Risk Along the Diabetes Continuum
|
N/A | |
Completed |
NCT04056208 -
Pistachios Blood Sugar Control, Heart and Gut Health
|
Phase 2 | |
Completed |
NCT02284893 -
Study to Evaluate the Efficacy and Safety of Saxagliptin Co-administered With Dapagliflozin in Combination With Metformin Compared to Sitagliptin in Combination With Metformin in Adult Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Therapy Alone
|
Phase 3 | |
Completed |
NCT04274660 -
Evaluation of Diabetes and WELLbeing Programme
|
N/A | |
Active, not recruiting |
NCT05887817 -
Effects of Finerenone on Vascular Stiffness and Cardiorenal Biomarkers in T2D and CKD (FIVE-STAR)
|
Phase 4 | |
Active, not recruiting |
NCT05566847 -
Overcoming Therapeutic Inertia Among Adults Recently Diagnosed With Type 2 Diabetes
|
N/A | |
Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
Completed |
NCT04965506 -
A Study of IBI362 in Chinese Patients With Type 2 Diabetes
|
Phase 2 | |
Recruiting |
NCT06115265 -
Ketogenic Diet and Diabetes Demonstration Project
|
N/A | |
Active, not recruiting |
NCT03982381 -
SGLT2 Inhibitor or Metformin as Standard Treatment of Early Stage Type 2 Diabetes
|
Phase 4 | |
Completed |
NCT04971317 -
The Influence of Simple, Low-Cost Chemistry Intervention Videos: A Randomized Trial of Children's Preferences for Sugar-Sweetened Beverages
|
N/A | |
Completed |
NCT04496154 -
Omega-3 to Reduce Diabetes Risk in Subjects With High Number of Particles That Carry "Bad Cholesterol" in the Blood
|
N/A | |
Completed |
NCT04023539 -
Effect of Cinnamomum Zeylanicum on Glycemic Levels of Adult Patients With Type 2 Diabetes
|
N/A | |
Recruiting |
NCT05572814 -
Transform: Teaching, Technology, and Teams
|
N/A | |
Enrolling by invitation |
NCT05530356 -
Renal Hemodynamics, Energetics and Insulin Resistance: A Follow-up Study
|
||
Completed |
NCT03960424 -
Diabetes Management Program for Hispanic/Latino
|
N/A | |
Completed |
NCT04097600 -
A Research Study Comparing Active Drug in the Blood in Healthy Participants Following Dosing of the Current and a New Formulation (D) Semaglutide Tablets
|
Phase 1 | |
Completed |
NCT05378282 -
Identification of Diabetic Nephropathy Biomarkers Through Transcriptomics
|
||
Active, not recruiting |
NCT06010004 -
A Long-term Safety Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes
|
Phase 3 | |
Completed |
NCT03653091 -
Safety & Effectiveness of Duodenal Mucosal Resurfacing (DMR) Using the Revita™ System in Treatment of Type 2 Diabetes
|
N/A |